Stephen Abreu Joins FPOC’s Board of Directors

Dear Colleagues:

I am writing to inform you that Mr. Stephen Abreu is joining For People of Color, Inc.’s Board of Directors. Steve is the first FPOC alumnus to join our Board. He attended my very first law school admissions workshop and I have proudly witnessed his career flourish over the years. Steve is a trusted friend and colleague who cares deeply about FPOC’s mission and the challenging diversity issues that are facing the profession.

Raised in a single parent household, Stephen grew up in the small town of Escondido in Southern California. He is of Latino descent: His mother is from Puerto Rico, and his father from the Dominican Republic. He attended UC Santa Cruz for his undergraduate and graduate degrees in molecular biology and UC Davis for law school. Like many of our constituency he worked throughout his undergraduate career to put himself through school and is the first in his family to attend college and law school.

He will be an invaluable asset as we continue to pursue our goal of taking FPOC to the next level.

With warmest regards,

Anthony Solana, Jr.
President & Chairperson
For People of Color, Inc.

Stephen Abreu

Stephen Abreu is an associate in King & Spalding’s Silicon Valley Corporate Practice Group. Mr. Abreu advises biotechnology, medical device and digital health companies on a range of complex technology and commercial agreements such as strategic partnering and collaboration agreements, intellectual property licenses with both commercial businesses and academic institutions, manufacturing and supply agreements and software licenses.

Mr. Abreu has extensive expertise in university transactions gained while working for the University of California, San Francisco as the Industry Contracts Manager for the Diabetes Center and the Immune Tolerance Network. In that capacity, Mr. Abreu was responsible for managing all industry relations between these departments and companies operating in the biotechnology, pharmaceutical and digital health space. During his tenure at UCSF Mr. Abreu negotiated and executed agreements governing:

•a US$20 million three-party public-private partnership with the California Institute for Regenerative Medicine and a biotechnology company specializing in stem-cell-delivered diabetes treatment
•a US$5 million collaborative program with a publicly traded biotechnology company for discovery and development of targets for the treatment of diabetes
•a US$4 million memorandum of understanding with the National Institute of Allergy and Infectious Diseases for studies of immune tolerance in kidney transplant patients

Mr. Abreu received his Masters degree in Molecular Biology from the University of California Santa Cruz, where he focused his research on characterizing vacuolar calcium exchangers and ATPase pumps in fungal model organisms.

Mr. Abreu has also worked as a bench scientist for several biotech companies with antibody-based technologies. He began his career working for the Wall Street investment firm Sanford Bernstein as an institutional asset associate where he earned his Series 7 and 63 licenses in 2000.

Mr. Abreu received his J.D. from the University of California, Davis School of Law in 2007, where he externed for the U.C. Davis Office of Technology Transfer and was president of the King Hall Intellectual Property Law Association and the Black Law Student’s Association. Mr. Abreu received the Sidney B. Williams Intellectual Property Scholarship, administered by the American Intellectual Property Law Association, in 2006.

In May 2011, Mr. Abreu was appointed an Adjunct Professor at the University of California, Davis Martin Luther King Jr. School of Law, where he teaches intellectual property transactions.

Prior to joining King & Spalding Mr. Abreu worked for an international law firm advising life sciences companies on technology and commercial agreements.

Mr. Abreu is fluent in Spanish and English.